Yoshihiro Tanaka, MD, PhD, on Predicting Bleeding Risk in Patients With AFib Taking DOACs
In this podcast, Yoshihiro Tanaka, MD, PhD, answers our questions about his team's study on predicting bleeding risk among patients with atrial fibrillation who are taking direct oral anticoagulants instead of\xa0warfarin. He also presented these findings at the\xa0American Heart Association\u2019s Scientific Sessions 2021. More at: www.consultant360.com